Central Retinal Artery Occlusion
Ophthalmology Retina · 2023
DOI: 10.1016/j.oret.2023.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Retina, 2023. Verfasst von Ronak Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Renaissance School of Medicine at Stony Brook University, Stony Brook, New York. Hauptthemen laut MEDLINE: Retinal Artery Occlusion. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the presentation patterns of patients diagnosed with central retinal artery occlusion (CRAO) from 2011 to 2020. DESIGN: Retrospective cohort study SUBJECTS: The present study was conducted in 484 patients presenting within 30 days of symptom onset with accurate documentation of time of symptom onset, time of presentation to the health care system, and time of presentation to an ophthalmologist. METHODS: An independent chart review of patients with CRAO was conducted. MAIN OUTCOME MEASURES: Demographic information including age, sex, and race were collected. Presentation patterns such as time of first symptoms, time of first contact with the health care system, and time of evaluation by an ophthalmologist were analyzed. Additionally, information regarding the medical venue or specialty of initial patient contact was collected. RESULTS: A total of 247 (51%) patients contacted the health care system within 4.5 hours of system onset, whereas 86 (17.8%) patients waited over 24 hours. Only 81 (32.8%) of the 247 patients who presented within 4.5 hours saw an ophthalmologist within that time frame, whereas 172 (35.5%) of the entire cohort of 484 did not present to an ophthalmologist within 24 hours of vision loss. There was significant variability with regards to medical specialty of initial patient contact, with 292 (60.3%) patients first presenting to an emergency department and 133 (27.5%) patients first presenting to an ophthalmologist. Black and Hispanic patients presented later than patients of White, Asian, or other racial backgrounds (40.4 ± 10.2 hours versus 23.0 ± 3.4 hours, P = 0.05). CONCLUSIONS: Although no level 1 evidence-based treatment is currently available for CRAO, thrombolytic therapy may be promising. Even though over half of patients with CRAO within our institution connected with the health care system within a potential window for thrombolytic therapy, most did not receive a definitive ophthalmic diagnosis within that time frame. Public health educational campaigns and infrastructure optimization must speed up presentation times, decrease the time to ophthalmic diagnosis, and target vulnerable populations to offer and research timely administration of thrombolytic therapy. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any materials discussed in this article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.
- Kaiser Permanente Northern California, Vallejo, California.
- Kaiser Permanente Northern California, Oakland, California.
- University of California Davis School of Medicine, Sacramento, California.
- University Hospitals at Case Western Reserve University, Cleveland, Ohio.
- Kaiser Permanente Northern California, Oakland, California. Electronic address: robin.vora@kp.org.
Zitieren
APA
Shah, R., Gilbert, A., Melles, R., Patel, A., Do, T., Wolek, M., & Vora, R. A. (2023). Central Retinal Artery Occlusion. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2023.01.005
Vancouver
Shah R, Gilbert A, Melles R, Patel A, Do T, Wolek M, et al. Central Retinal Artery Occlusion. Ophthalmology Retina. 2023. doi:10.1016/j.oret.2023.01.005
BibTeX
@article{Shah2023,
author = {Shah, Ronak and Gilbert, Aubrey and Melles, Ronald and Patel, Amar and Do, Timothy and Wolek, Michael and Vora, Robin A},
title = {Central Retinal Artery Occlusion},
journal = {Ophthalmology Retina},
year = {2023},
doi = {10.1016/j.oret.2023.01.005}
}
EUVIMED